Increased TRIM11 mRNA expression-compared to normal tissue- has been described in hepatocellular carcinoma, which translated to increased protein expression by IHC [16], lung non-small cell carcinoma (NSCC) [15], prostatic, colonic, gastric adenocarcinomas [17,18,19], and lymphoma [20]. This evidence concerns the gene TRIM11 and lymphoma.